Selective serotonin reuptake inhibitors vs placebo
Proportion of participants with adverse effects ‐ measured over 8 weeks · primary Raynaud's phenomenon
It is very uncertain whether selective serotonin reuptake inhibitors changes adverse events (over 4 weeks) compared with placebo (very low certainty).
1 finding from 1 review
- RR 1.54 [0.89, 2.66]1 study · 41 participantsVery low